DHGWA
BSX icon

Dixon Hughes Goodman Wealth Advisors’s Boston Scientific BSX Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5K Hold
102
– – ﹤0.01% 590
2021
Q4 		$4K Buy
+102
New +$4.29K ﹤0.01% 575

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's BSX Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors held its Boston Scientific (BSX) position steady in Q1 2022 at 102 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

Dixon Hughes Goodman Wealth Advisors first reported a position in BSX in Q4 2021 and has held it in 2 quarters since. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Dixon Hughes Goodman Wealth Advisors held 102 shares of Boston Scientific worth $5K as of Q1 2022.
  • Dixon Hughes Goodman Wealth Advisors left its Boston Scientific share count unchanged in Q1 2022.
  • Boston Scientific made up ﹤0.01% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #590 holding.
  • Dixon Hughes Goodman Wealth Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 2 quarters since.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.